Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Polycystic Ovary Syndrome × Ovidrel × Clear all

Phase

Status

Completed 3 Withdrawn 1 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 1 Obesity 1 Hyperandrogenism 1

Interventions

Metformin 30 Clomiphene 8 Letrozole 7 Triptorelin Pamoate 5 Inositol 5 drospirenone and ethinyl estradiol combination 4 Progesterone 4 Ethinyl Estradiol 4 Acupuncture Therapy 4 drospirenone 3 cetrorelix 3 Folic Acid 3 Estradiol 3 Diet, Mediterranean 3 Diet 3 Cyproterone acetate, ethinyl estradiol drug combination 3 Contraceptives, Oral 3 adrenosterone 2 Ultrasonography 2 Therapeutics 2 Spironolactone 2 Sitagliptin Phosphate 2 Simvastatin 2 Musculoskeletal Manipulations 2 Hematologic Tests 2 Gonadotropins 2 Flutamide 2 Dydrogesterone 2 Dexamethasone 2 Dehydroepiandrosterone 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01421810 2023-10-27

CBS001

University of Virginia

Phase NA Unknown

Obesity, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡